Intimation of resignation of Dr. Sanjay Chaturvedi, CEO of Apitoria Pharma Private Limited, wholly owned subsidiary of the Company.
AUROPHARMA · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Aurobindo Pharma has announced the resignation of Dr. Sanjay Chaturvedi as Chief Executive Officer of Apitoria Pharma Private Limited, its wholly owned subsidiary. Dr. Chaturvedi cited moving on to a different opportunity as the reason for his departure. He has been relieved from services effective close of business hours on May 4, 2026. The company has informed stock exchanges about this change as per regulatory requirements. The filing was signed by Company Secretary B. Adi Reddy.
The resignation of a subsidiary CEO is relatively minor for Aurobindo Pharma shareholders, as it does not affect the parent company's top leadership. However, it signals some management transition at the subsidiary level and investors may watch for the appointment of a replacement.